U.S. Life Sciences Stock News

NPK International (NPKI), a US based temporary worksite access solutions company, recently completed its rebrand from Newpark Resources, bringing fresh attention to a stock with mixed short term and longer term return profiles. See our latest analysis for NPK International. At a share price of US$14.28, NPK International has cooled in the very short term, with the share price down 2.33% over 1 day and 4.48% over 30 days. However, the year to date share price return of 18.02% and 1 year total...

CBL & Associates Properties (CBL) is back in focus after selling a 10.47 acre parcel near Harford Mall and lining up new retailers and restaurants at West County Center, including The Cheesecake Factory and POP MART. See our latest analysis for CBL & Associates Properties. These tenant additions and land sales sit against a solid run in the stock, with a 90-day share price return of 26.75% and a 1-year total shareholder return of 100.90%. This points to momentum that investors are watching...

Earlier this week, Sea Limited was caught in a broad selloff of high-valuation digital platforms after strong US payroll data reinforced expectations for interest rates staying higher for longer, pressuring growth-focused technology names sensitive to discount rates. This shift in macro sentiment highlights how Sea’s market value can be heavily influenced by changes in interest rate expectations, beyond its own earnings revisions and valuation debates. We’ll now examine how renewed worries...

Public Service Enterprise Group has recently completed a US$499.31 million fixed-income offering of 4.800% senior unsecured notes due June 15, 2031, priced at 99.861% of the US$500 million principal, and filed to cut New Jersey residential gas heating bills by 5% from October 1, 2026. Together, the bond issuance and planned bill reduction highlight how PSE&G is funding its capital needs while emphasizing affordability for its 1.9 million gas customers. With this planned 5% cut to residential...

Lantheus Holdings (LNTH) is back in focus after its investigational PET/CT agent LNTH-2513 (18F-GP1) earned SNMMI’s Image of the Year, tied to clinical data in acute lower-extremity deep vein thrombosis. See our latest analysis for Lantheus Holdings. The award news comes as Lantheus shares trade at US$100.98, with a 30 day share price return of 8.51% and a 90 day share price return of 26.21%. The 5 year total shareholder return is very large, suggesting momentum has been building over both...

Nuvalent, Inc. recently announced that the U.S. FDA accepted New Drug Applications for its investigational lung cancer therapies neladalkib and zidesamtinib, granting Priority Review to neladalkib and setting target action dates of September 18 and November 27, 2026, respectively. Together with the appointment of Georg Pirmin Meyer, M.D., as Chief International Officer, these milestones highlight Nuvalent’s push to build a global commercial footprint around its late-stage oncology...

Kodiak Sciences recently reported that its Phase III GLOW2 trial of Zenkuda for diabetic retinopathy met primary and key secondary endpoints with strong efficacy, and the company is also advancing multiple late-stage ophthalmology programs while maintaining a solid, debt-free balance sheet. This combination of positive late-stage data and an accelerated regulatory submission plan highlights how central Zenkuda has become to Kodiak’s overall pipeline story. Next, we’ll examine how Zenkuda’s...

Why Southwest Gas Holdings (SWX) is Back on Investor Radars Southwest Gas Holdings (SWX) has drawn fresh attention after unveiling a US$6.3 billion investment plan for 2026 to 2030, paired with higher earnings estimates and reaffirmed 2026 guidance for its regulated utility business. See our latest analysis for Southwest Gas Holdings. The reaffirmed 2026 guidance and US$6.3b investment plan come as Southwest Gas Holdings trades at US$88.72, with a year-to-date share price return of 10.69% and...

IDEAYA Biosciences (IDYA) has moved into focus after two clinical updates, a new collaboration with Roche on IDE892 plus RG6505 in MTAP deleted pancreatic cancer, and Phase 2/3 darovasertib data in metastatic uveal melanoma. See our latest analysis for IDEAYA Biosciences. Despite the recent collaboration with Roche and positive darovasertib data at ASCO, IDEAYA Biosciences’ share price has come under pressure in recent months, with a 90 day share price return down 19.4%, although the 1 year...

In the first quarter of 2026, Melco Resorts & Entertainment’s Macau properties generated 87% of group gross gaming revenue and 75% of EBITDA, with both metrics expanding year-on-year and quarter-on-quarter alongside a 1.3 percentage point gain in Macau gross gaming revenue market share. This outperformance in Macau, coupled with Melco’s ongoing support for inclusion-focused events such as the 2026 Inclusion Conference & Festival and the Macau Golf Masters, highlights how operational strength...

In late April 2026, Weyerhaeuser reported Q1 results that topped expectations, with US$1.73 billion in net sales, US$77 million in adjusted net earnings, and completion of a US$192 million divestiture of 108,000 acres of non-core Virginia timberlands. Beyond the quarterly beat, the sale of lower-priority timberlands and progress in higher-margin Wood Products and Strategic Land Solutions highlight how Weyerhaeuser is reshaping its portfolio toward higher-return uses of its asset base. Next,...

Pilgrim's Pride (PPC) is back in focus after recent analyst commentary highlighted expectations for lower earnings this quarter and for the fiscal year, alongside a Zacks Rank #5 (Strong Sell) rating. See our latest analysis for Pilgrim's Pride. At a share price of US$29.88, Pilgrim's Pride has seen short term strength with a 1 day share price return of 3.14% and a 7 day gain of 5.55%. However, momentum has faded over the past quarter, with the 90 day share price return down 24.79% and the 1...

In recent developments, Energy Vault Holdings reported very large year-over-year revenue growth for fiscal 2025, driven by project execution in Australia and the U.S., the ramp-up of its Asset Vault portfolio, and US$450 million of new strategic financing, while shareholders reelected three Class II directors and ratified BDO USA, P.C. as auditor for the fiscal year ending December 31, 2026. Together, the rapid expansion of contracted capacity to 540 megawatts and the move into AI-focused...

C.H. Robinson Worldwide recently launched its Lean AI Engineer, an AI system that can assess and optimize a shipper’s global supply chain in under 30 minutes, working alongside the existing Lean AI Planner to autonomously manage the vast majority of 4PL shipments across trucking, ocean, air, and rail. Early customer results highlight how this AI platform can uncover hidden efficiencies and cost savings, such as materially reducing shipment frequency and load counts by reconfiguring schedules...

Qorvo (QRVO) is back in focus after its latest quarterly report delivered revenue and adjusted earnings above analyst estimates. The results were helped by tighter cost control and a product mix that is less exposed to soft smartphone demand. See our latest analysis for Qorvo. Despite a 1-day share price decline of 5.47% to US$98.28 after the report, Qorvo still shows a 30 day share price return of 8.56% and a 1 year total shareholder return of 25.07%. However, 5 year total shareholder...

Earlier this month at COMPUTEX 2026, Micron Technology showcased a full stack of AI-optimized memory and storage products, from HBM4 and advanced DRAM to ultra–high-capacity SSDs, aimed at data center and edge AI workloads, while concurrently signing multi-year supply agreements to secure long-term demand during an industry-wide memory shortage. At the same time, sector-wide concern about the pace of AI chip spending, sparked by Broadcom’s cautious outlook, triggered heavy profit-taking in...

The Toro Company recently reported past fiscal second-quarter 2026 results showing sales of US$1,424.7 million and net income of US$145.4 million, with both basic and diluted earnings per share from continuing operations rising year on year. Alongside this, Toro raised its full-year 2026 net sales growth guidance to a 4.0%–6.5% range, underpinned by broad-based demand, improving margins, and early benefits from its AMP productivity program and the Tornado acquisition. With Toro lifting its...

In the past quarter, Cullen/Frost Bankers reported year-on-year revenue growth but missed analysts’ expectations, particularly on net interest income and overall revenues. This mixed outcome highlights the tension between Frost’s expanding Texas franchise and near-term pressure on its core banking income streams. Next, we’ll examine how the net interest income shortfall interacts with Frost’s Texas-focused growth narrative and long-term profitability assumptions. We've uncovered the 9...

In late May, Graham Corporation presented at the KeyBanc Capital Markets 2026 Industrials & Basic Materials Conference in Boston, highlighting its role in industrial fluid and energy systems. This appearance comes just ahead of its scheduled earnings announcement, drawing attention to how management frames recent operational momentum and future demand drivers. Next, we’ll examine how anticipation around Graham’s upcoming earnings announcement and conference messaging may influence its...

Edwards Lifesciences recently raised its full-year 2026 sales and TAVR growth guidance and completed the acquisition of Autus Valve Technologies, further expanding its structural heart portfolio beyond TAVR. This combination of higher guidance and broader coverage across aortic, mitral, and tricuspid therapies underscores how Edwards is deepening its role in treating complex structural heart disease. Next, we’ll examine how the upgraded sales outlook, particularly for TAVR, may reshape...

Apollo Global Management (APO) just reported Q1 2026 earnings that missed analyst estimates. At the same time, assets under management crossed US$1t, paired with a sizable share repurchase and an ongoing dividend program. See our latest analysis for Apollo Global Management. The share price has eased in the short term, with a 1 month share price return of down 3.9% and a year to date share price return of down 12.7%, even though the 3 year total shareholder return of about 84% and 5 year...

Forgent Power Solutions, Inc. recently completed a follow-on equity offering of approximately US$1.99 billion, issuing 42,280,000 Class A common shares at US$47 each, slightly below the reference price. This capital raise follows the company’s move to reprice its senior credit facilities and target lower interest costs, highlighting an active approach to reshaping its capital structure. We’ll now examine how this large equity raise, alongside the repriced credit facilities, may influence...

In late May 2026, Seacoast Banking Corporation of Florida disclosed that long-serving director H. Gilbert Culbreth, Jr. will resign from its Board on June 15, 2026, for personal reasons while remaining on the board of Seacoast National Bank and stepping away from the compensation and governance committee. This governance change coincides with scrutiny of Seacoast’s lower net interest margin, flat earnings per share over five years, and declining tangible book value per share, underscoring...

In recent days, KKR has been linked to a potential acquisition of a 25% stake in India’s Cloudnine maternity and pediatric hospital chain at an implied value of about INR 100,000 million (US$1.00 billion), while also progressing plans to open a new Milan office to deepen its Italian private markets and wealth footprint. At the same time, sector-wide liquidity concerns triggered by Partners Group’s decision to cap withdrawals from a large private equity fund have put a spotlight on how KKR’s...